Dopaminergic drugs in development for Parkinson's disease

被引：0

|

作者：

Korczyn, AD ^{[1
]}

机构：

[1] Tel Aviv Univ, Sch Med, Sieratzki Chair Neurol, Ramat Aviv, Israel

来源：

PARKINSON'S DISEASE | 2003年 / 91卷

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

收藏

页码：267 / 271

页数：5

相关论文

共 50 条

[31] Continuous dopaminergic stimulation in Parkinson's disease
Silverdale, Monty
PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2007, 11 (01) : 24 - 28
[32] Dopaminergic dysregulation syndrome in Parkinson's disease
Katzenschlager, Regina
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 271 - 275
[33] Initiating dopaminergic treatment in Parkinson's disease
Lang, Anthony E.
Marras, Connie
LANCET, 2014, 384 (9949): : 1164 - 1166
[34] Depression and Parkinson's disease - The dopaminergic link
Leentjens, A. F. G.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S145 - S146
[35] Dopaminergic Neuroprotection with Atremorine in Parkinson's Disease
Carrera, Ivan
Fernandez-Novoa, Lucia
Sampedro, Carolina
Tarasov, Vadim V.
Aliev, Gjumrakch
Cacabelos, Ramon
CURRENT MEDICINAL CHEMISTRY, 2018, 25 (39) : 5372 - 5388
[36] Dopaminergic impairment and neuroinflammation in Parkinson's disease
Ouchi, Yasuomi
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 22P - 22P
[37] Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Mortimer Mamelak
Neurology and Therapy, 2018, 7 : 5 - 11
[38] Quantification of the dopaminergic response in Parkinson's disease
Müller, T
Benz, S
PARKINSONISM & RELATED DISORDERS, 2002, 8 (03) : 181 - 186
[39] Parkinson's Disease Dopaminergic therapy optimizes
Setton, Juergen
NERVENHEILKUNDE, 2011, 30 (1-2) : 94 - 94
[40] Parkinson's disease and RLS: the dopaminergic bridge
Rye, DB
SLEEP MEDICINE, 2004, 5 (03) : 317 - 328

← 1 2 3 4 5 →